Biolife Solutions, Inc.
A biopreservation company that keeps living cells alive through freezing, storage, and shipping. Its media — CryoStor and HypoThermosol — plus thawing systems like ThawSTAR are used by cell and gene therapy developers worldwide. Incorporated in Delaware in 1998 and headquartered in Bothell, Washington, its HypoThermosol technology grew out of University of Minnesota research on preserving organs.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Casdin Capital, LLC | 13GPassive | 9.7% | 4.76M | Jun 4, 2026 |
| Casdin Partners Master Fund, L.P. | 13GPassive | 9.7% | 4.76M | Jun 4, 2026 |
| Casdin Partners GP, LLC | 13GPassive | 9.7% | 4.76M | Jun 4, 2026 |
| Eli Casdin | 13GPassive | 9.7% | 4.76M | Jun 4, 2026 |
| T. Rowe Price Investment Management, Inc. | 13G/APassive | 13.5% | 6.51M | May 15, 2026 |
| Invesco Ltd. | 13G/APassive | 4.9% | 2.35M | May 6, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |